Literature DB >> 26399208

Management of previously treated tuberculosis patients in Kalutara district, Sri Lanka: how are we faring?

S C Abeygunawardena1, B N Sharath2, R Van den Bergh3, B Naik4, N Pallewatte5, M N N Masaima6.   

Abstract

SETTING: District Chest Clinic, Kalutara, Sri Lanka.
OBJECTIVES: To determine the coverage of culture and drug susceptibility testing (CDST), delays in CDST, treatment initiation, obtaining CDST results and treatment outcomes of previously treated tuberculosis (TB) patients.
DESIGN: Retrospective cohort study involving review of records and reports. All previously treated TB patients from January 2008 to June 2013 were included in the study.
RESULTS: Of 160 patients, 126 (79%) samples were sent for CDST; 79 (63%) were culture-positive and no multi-drug-resistant (MDR) TB cases were reported. Respectively 9% and 15% of patients experienced a delay in sending samples (median delay 21 days) and receiving CDST reports (median delay 71 days), while 20% experienced delays in initiating the retreatment regimen (median delay 11.5 days). The cohort recorded an 82% treatment success rate.
CONCLUSION: Of all retreatment patients, only 79% were tested for CDST and there were sizeable delays in sample transportation and treatment initiation. Possible ways forward to strengthen the programme are discussed.

Entities:  

Keywords:  culture and DST; operational delays; treatment outcome; tuberculosis

Year:  2014        PMID: 26399208      PMCID: PMC4539044          DOI: 10.5588/pha.13.0111

Source DB:  PubMed          Journal:  Public Health Action        ISSN: 2220-8372


  9 in total

1.  Tuberculosis 'retreatment others': profile and treatment outcomes in the state of Andhra Pradesh, India.

Authors:  S Srinath; B Sharath; K Santosha; S S Chadha; S Roopa; K Chander; F Wares; L S Chauhan; N C Wilson; A D Harries
Journal:  Int J Tuberc Lung Dis       Date:  2011-01       Impact factor: 2.373

2.  Management and outcome of tuberculosis patients who fail treatment under routine programme conditions in Malawi.

Authors:  A D Harries; T E Nyirenda; J R Kemp; B S Squire; P Godfrey-Faussett; F M L Salaniponi
Journal:  Int J Tuberc Lung Dis       Date:  2003-11       Impact factor: 2.373

3.  Prevalence of hypertension, diabetes and obesity: baseline findings of a population based survey in four provinces in Sri Lanka.

Authors:  K Wijewardene; M R Mohideen; S Mendis; D S Fernando; T Kulathilaka; D Weerasekara; P Uluwitta
Journal:  Ceylon Med J       Date:  2005-06

4.  Performance of culture and drug susceptibility testing in pulmonary tuberculosis patients in northern China.

Authors:  W Qi; A D Harries; S G Hinderaker
Journal:  Int J Tuberc Lung Dis       Date:  2011-01       Impact factor: 2.373

5.  Fluorescein diacetate vital staining allows earlier diagnosis of rifampicin-resistant tuberculosis.

Authors:  A Van Deun; A K J Maug; A Hossain; M Gumusboga; B C de Jong
Journal:  Int J Tuberc Lung Dis       Date:  2012-06-28       Impact factor: 2.373

6.  Patterns of drug resistance and RFLP analysis of Mycobacterium tuberculosis strains isolated from recurrent tuberculosis patients in Sri Lanka.

Authors:  D N Magana-Arachchi; A J Perera; V Senaratne; N V Chandrasekharan
Journal:  Southeast Asian J Trop Med Public Health       Date:  2010-05       Impact factor: 0.267

7.  Acquired drug resistance pattern in tuberculosis cases at the State Tuberculosis Centre, Delhi, India.

Authors:  M Hanif; S Malik; V K Dhingra
Journal:  Int J Tuberc Lung Dis       Date:  2009-01       Impact factor: 2.373

8.  Operational challenges in diagnosing multi-drug resistant TB and initiating treatment in Andhra Pradesh, India.

Authors:  Sarabjit S Chadha; B N Sharath; Kishore Reddy; Jyothi Jaju; P H Vishnu; Sreenivas Rao; Malik Parmar; Srinath Satyanarayana; Kuldeep Singh Sachdeva; Nevin Wilson; Anthony D Harries
Journal:  PLoS One       Date:  2011-11-02       Impact factor: 3.240

9.  Linkage of presumptive multidrug resistant tuberculosis (MDR-TB) patients to diagnostic and treatment services in Cambodia.

Authors:  Sokhan Khann; Eang Tan Mao; Yadav Prasad Rajendra; Srinath Satyanarayana; Sharath Burugina Nagaraja; Ajay M V Kumar
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240

  9 in total
  13 in total

1.  Does research through Structured Operational Research and Training (SORT IT) courses impact policy and practice?

Authors:  A M V Kumar; H D Shewade; J P Tripathy; N Guillerm; K Tayler-Smith; S Dar Berger; K Bissell; A J Reid; R Zachariah; A D Harries
Journal:  Public Health Action       Date:  2016-01-04

2.  MDR-TB in Puducherry, India: reduction in attrition and turnaround time in the diagnosis and treatment pathway.

Authors:  H D Shewade; S Govindarajan; P Thekkur; C Palanivel; M Muthaiah; A M V Kumar; V Gupta; B N Sharath; J P Tripathy; K Vivekananda; G Roy
Journal:  Public Health Action       Date:  2016-12-21

3.  Delay and attrition before treatment initiation among MDR-TB patients in five districts of Gujarat, India.

Authors:  H D Shewade; K S Shringarpure; M Parmar; N Patel; S Kuriya; S Shihora; N Ninama; N Gosai; R Khokhariya; C Popat; H Thanki; B Modi; P Dave; R K Baxi; A M V Kumar
Journal:  Public Health Action       Date:  2018-06-21

4.  MDR-TB screening in a setting with molecular diagnostic techniques: who got tested, who didn't and why?

Authors:  H D Shewade; S Govindarajan; B N Sharath; J P Tripathy; P Chinnakali; A M V Kumar; M Muthaiah; K Vivekananda; A K Paulraj; G Roy
Journal:  Public Health Action       Date:  2015-06-21

5.  The Multi-Drug Resistant Tuberculosis Diagnosis and Treatment Cascade in Bangladesh.

Authors:  Sarder Tanzir Hossain; Petros Isaakidis; Karuna D Sagili; Shayla Islam; Md Akramul Islam; Hemant Deepak Shewade; S M Mostofa Kamal; Ashaque Husain
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

6.  Has introduction of rapid drug susceptibility testing at diagnosis impacted treatment outcomes among previously treated tuberculosis patients in Gujarat, India?

Authors:  Paresh Dave; Bhavin Vadera; Ajay M V Kumar; Palanivel Chinnakali; Bhavesh Modi; Rajesh Solanki; Pranav Patel; Prakash Patel; Kirit Pujara; Pankaj Nimavat; Amar Shah; Sandeep Bharaswadkar; Kiran Rade; Malik Parmar; Sreenivas Achuthan Nair
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

7.  Provider reported barriers and solutions to improve testing among tuberculosis patients 'eligible for drug susceptibility test': A qualitative study from programmatic setting in India.

Authors:  Hemant Deepak Shewade; Arun M Kokane; Akash Ranjan Singh; Malik Parmar; Manoj Verma; Prabha Desikan; Sheeba Naz Khan; Ajay M V Kumar
Journal:  PLoS One       Date:  2018-04-20       Impact factor: 3.240

8.  Overcoming the health system barriers to early diagnosis and management of multidrug-resistant tuberculosis in a rural setting in North India.

Authors:  Mohammad Abu Bashar; Arun Aggarwal; Sudip Bhattacharya
Journal:  BMJ Case Rep       Date:  2020-01-21

9.  Characteristics and Treatment Outcomes of Retreatment Tuberculosis Patients in Benin.

Authors:  Serge Ade; Omer Adjibodé; Prudence Wachinou; Narcisse Toundoh; Bérénice Awanou; Gildas Agodokpessi; Dissou Affolabi; Gabriel Adè; Anthony D Harries; Séverin Anagonou
Journal:  Tuberc Res Treat       Date:  2016-03-24

10.  High pre-diagnosis attrition among patients with presumptive MDR-TB: an operational research from Bhopal district, India.

Authors:  Hemant Deepak Shewade; Arun M Kokane; Akash Ranjan Singh; Manoj Verma; Malik Parmar; Ashish Chauhan; Sanjay Singh Chahar; Manoj Tiwari; Sheeba Naz Khan; Vivek Gupta; Jaya Prasad Tripathy; Mukesh Nagar; Sanjai Kumar Singh; Pradeep Kumar Mehra; Ajay Mv Kumar
Journal:  BMC Health Serv Res       Date:  2017-04-04       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.